Your session is about to expire
← Back to Search
IDX-1197 + Chemotherapy for Stomach Cancer
Study Summary
This trial is testing a new drug for safety and how well it works with other drugs to treat advanced gastric cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have advanced stomach cancer and have had at least 2 rounds of chemotherapy.I am fully active or can carry out light work.I have no ongoing major side effects from previous treatments.My heart's electrical activity is abnormal, or I have a family history of long QT syndrome.I have been diagnosed with myelodysplastic syndrome or acute myeloid leukemia.My high blood pressure is not under control.I have advanced or recurrent stomach cancer that has not been treated yet.I have at least one tumor that can be measured or evaluated.I do not have any uncontrolled illnesses like severe infections, diabetes, or liver, kidney, or lung diseases.I am not taking any strong medication that affects liver enzymes.I have had cancer spread to the lining of my brain and spinal cord.I haven't had serious heart issues or surgeries in the last 6 months.I have an active Hepatitis B or C infection.I am HER2 positive.I have symptoms from brain metastasis that are not under control.I do not have active or symptomatic pneumonitis, nor a history of it requiring steroids.
- Group 1: Group 2
- Group 2: Group 1
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many research centers are currently participating in this experiment?
"Currently, 5 medical centres are running this clinical trial. These sites can be found in Baton Rouge, Philadelphia and Los Angeles in addition to 2 other locations. To facilitate participation, it is advised that individuals choose a site as close to them as possible to curtail any necessary transportation costs."
To which ailments is this particular therapy regularly applied?
"This therapeutic intervention is routinely used in cases of malignant pancreatic neoplasms. Furthermore, it can be employed as a treatment option for diverse illnesses such as metastatic tumors, stomach cancer, and rhabdomyosarcomas."
Does this treatment have the official endorsement of the FDA?
"With only minimal data available to access the safety and efficacy of this treatment, it has been assigned a score of 1."
Are there any historical precedents for this particular therapy approach?
"Research into this particular treatment first began in 2002 at Mayo Clinic, Rochester. To date, 512 trials have ended and 263 are still ongoing; Baton Rouge is a hub of activity for these studies."
Is there an upper limit to the number of people who can take part in this experiment?
"Affirmative. On clinicaltrials.gov, it is noted that this research trial was initially posted on June 28th 2021 and is currently seeking 100 participants across 5 sites. It has been recently revised as of August 7 2022."
Are there any opportunities for individuals to participate in this research endeavor?
"As per the clinicaltrials.gov website, this trial is in progress and recruitment of suitable candidates has commenced since June 28th 2021 - with a most recent update on August 7th 2022."
Share this study with friends
Copy Link
Messenger